跳至主要内容
临床试验/NL-OMON49959
NL-OMON49959已完成不适用

Real-time Amino acid Profiling - 2 - RAP-2 study

FrieslandCampina Research0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Age *65 and *80
  • * BMI *20 and *32 kg/m2
  • * Non-smoking
  • * Healthy as assessed by the NIZO lifestyle and health questionnaire
  • (*Verklaring leefgewoonten en gezondheid*) and according to the judgment of the
  • study physician.
  • * Regular and normal Dutch eating habits as assessed by the NIZO lifestyle and
  • health questionnaire (3 main meals per day)
  • * Veins suitable for cannulation (blood sampling)
  • * Voluntary participation
  • * Having given written informed consent
  • * Willing to comply with study procedures
  • * Accept use of all encoded data, including publication, and the confidential
  • use and storage of all data for 15 years.
  • * Accept disclosure of the financial benefit of participation in the study to
  • the authorities concerned

排除标准

  • * Participation in any clinical trial including blood sampling and/or
  • administration of substances up to 30 days before day 1 of this study
  • * Having a history of medical or surgical events that may significantly affect
  • the study outcome, including: Inflammatory bowel disease, hepatitis,
  • pancreatitis, ulcers, gastrointestinal or rectal bleeding; major
  • gastrointestinal tract surgery such as gastrectomy, gastroenterostomy, or bowel
  • resection; known or suspected gastrointestinal disorders, colon or GI tract
  • * Use of the following medication: glucose lowering drugs, insulin; medication
  • that may impact gastric emptying (e.g. gastric acid inhibitors or laxatives)
  • * Diagnosed with diabetes, being treated for high blood glucose or increased
  • fasting blood glucose (> 7 mmol/l in finger prick blood) as assessed during
  • screening visit
  • * For men: Hb <8,5 mmol/l as assessed during screening visit; for women: Hb
  • <7,5 mmol/l.
  • * Use of protein supplements
  • * Mental status that is incompatible with the proper conduct of the study
  • * A self-reported reported food allergy or sensitivity to dairy ingredients
  • * Alcohol consumption for men > 28 units/week and >4/day; for women: >21
  • units/week and >3/day
  • * Reported unexpected weight loss or weight gain of > 3 kg in the month prior
  • to pre-study screening, or intention to lose weight during the study period
  • * Reported slimming or medically prescribed diet
  • * Recent blood donation (<1 month prior to Day 01 of the study)
  • * Not willing to give up blood donation during the study
  • * Personnel of NIZO food research and FrieslandCampina, their partner and their
  • first and second degree relatives
  • * Not having a general practitioner
  • * Not willing to accept information-transfer concerning participation in the
  • study, or information regarding his or her health, like laboratory results and
  • eventual adverse events to and from his general practitioner

研究者

发起方
FrieslandCampina Research

相似试验